1. 2022-LBA-677-ESGO Distribution and prognostic role of BRCA status in elderly ovarian cancer patients. (27th October 2022) Authors: Tortorella, Lucia; Cappuccio, Serena; Marchetti, Claudia; Costantini, Barbara; Giannarelli, Diana; Vizzielli, Giuseppe; Pasciuto, Tina; Lorusso, Domenica; Scambia, Giovanni; Fagotti, Anna Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1206-ESGO Selection of preexisting BRCA1/2-proficient tumor cells in BRCA1/2-driven tubo-ovarian carcinomas treated by neoadjuvant chemotherapy. (20th October 2022) Authors: Imyanitov, Evgeny; Marchetti, Claudia; Sokolenko, Anna; Piermattei, Alessia; Gorodnova, Tatiana; Pavone, Matteo; Ivantsov, Alexandr; Scambia, Giovanni; Kuligina, Ekatherina; Berlev, Igor; Fagotti, Anna Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-1356-ESGO Epithelial ovarian cancer and brain metastases: survival analysis according to the BRCA status. (20th October 2022) Authors: Sassu, Carolina Maria; Marchetti, Claudia; Russo, Giorgia; Minucci, Angelo; Boccia, Serena Maria; Piermattei, Alessia; Mattogno, Pier Paolo; Benato, Alberto; Olivi, Alessandro; Fagotti, Anna; Scambia, Giovanni Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2022-RA-1367-ESGO Clinical and survival data of early-stage tubo-ovarian carcinoma according to BRCA mutational status. A large, multicenter, retrospective study. (20th October 2022) Authors: Marchetti, Claudia; Ataseven, Beyhan; Perrone, Anna Myriam; Cassani, Chiara; Fruscio, Robert; Sassu, Carolina Maria; Apostol, Adriana Ionelia; Harter, Philipp; Traut, Alexander; de Iaco, Pierandrea; Arbustini, Eloisa; Bizzarri, Nicolò; Schneider, Stephanie; Rhiem, Kerstin; Stanislao, Marco Di; Ur... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2022-RA-1375-ESGO Minimally invasive vs. open interval debulking surgery in advanced ovarian cancer patients: pattern of recurrence and oncological outcome in a propensity matched population. (20th October 2022) Authors: Conte, Carmine; Rosati, Andrea; Marchetti, Claudia; Aterno, Donatella; Alletti, Salvatore Gueli; Scambia, Giovanni; Fagotti, Anna Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2022-RA-1470-ESGO Is neoadjuvant chemotherapy effective as prehabilitation program in advanced epithelial ovarian cancer?. (20th October 2022) Authors: Ghirardi, Valentina; Marchetti, Claudia; Ferrante, Maria Giulia; Faustini, Alice Zampolini; Scambia, Giovanni; Fagotti, Anna Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 2022-RA-1623-ESGO Effect of bevacizumab and complete cytoreductive surgery in advanced low grade serous ovarian cancer: a secondary analysis of MITO 22. (20th October 2022) Authors: Musacchio, Lucia; Turinetto, Margherita; Bartoletti, Michele; Arenare, Laura; Califano, Daniela; Tuninetti, Valentina; Cormio, Gennaro; Pisano, Carmela; Valabrega, Giorgio; Marchetti, Claudia; Cecere, Sabrina Chiara; Greggi, Stefano; Raspagliesi, Francesco; Perrone, Francesco; Fagotti, Anna; Loru... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2022-RA-634-ESGO Trabectedin plus pegylated liposomaldoxorubicin in patients who experienced disease progression after PARPi maintenance: a real life case-control study. (20th October 2022) Authors: Vertechy, Laura; Boccia, Serena Maria; Tiberi, Giordana; Corrado, Giacomo; Fagotti, Anna; Scambia, Giovanni; Marchetti, Claudia Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 2022-RA-685-ESGO What is beyond brca mutational status in high grade serous ovarian cancer? The role of hormone receptors expression. (20th October 2022) Authors: Perrone, Emanuele; Tudisco, Riccardo; Pafundi, Pia Clara; Guido, Davide; Ciucci, Alessandra; Martinelli, Enrica; Zannoni, Gian Franco; Piermattei, Alessia; Marchetti, Claudia; Nero, Camilla; Gallo, Daniela; Scambia, Giovanni; Fagotti, Anna Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 2022-RA-820-ESGO The role of minimally invasive secondary cytoreduction in recurrent ovarian cancer patients. (20th October 2022) Authors: Conte, Carmine; Marchetti, Claudia; Loverro, Matteo; Giudice, Maria Teresa; Rosati, Andrea; Gallotta, Valerio; Scambia, Giovanni; Fagotti, Anna Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗